<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8728143</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkab1086</article-id>
    <article-id pub-id-type="publisher-id">gkab1086</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>The Human Proteoform Atlas: a FAIR community resource for experimentally derived proteoforms</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0797-3134</contrib-id>
        <name>
          <surname>Hollas</surname>
          <given-names>Michael A R</given-names>
        </name>
        <aff><institution>Departments of Molecular Biosciences, Chemistry, and the Chemistry of Life Processes Institute, Northwestern University</institution>, <addr-line>Evanston</addr-line>, <addr-line>IL</addr-line> <addr-line>60208</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3596-9597</contrib-id>
        <name>
          <surname>Robey</surname>
          <given-names>Matthew T</given-names>
        </name>
        <aff><institution>Departments of Molecular Biosciences, Chemistry, and the Chemistry of Life Processes Institute, Northwestern University</institution>, <addr-line>Evanston</addr-line>, <addr-line>IL</addr-line> <addr-line>60208</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0710-3462</contrib-id>
        <name>
          <surname>Fellers</surname>
          <given-names>Ryan T</given-names>
        </name>
        <aff><institution>Departments of Molecular Biosciences, Chemistry, and the Chemistry of Life Processes Institute, Northwestern University</institution>, <addr-line>Evanston</addr-line>, <addr-line>IL</addr-line> <addr-line>60208</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6951-2923</contrib-id>
        <name>
          <surname>LeDuc</surname>
          <given-names>Richard D</given-names>
        </name>
        <aff><institution>Departments of Molecular Biosciences, Chemistry, and the Chemistry of Life Processes Institute, Northwestern University</institution>, <addr-line>Evanston</addr-line>, <addr-line>IL</addr-line> <addr-line>60208</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2887-4765</contrib-id>
        <name>
          <surname>Thomas</surname>
          <given-names>Paul M</given-names>
        </name>
        <aff><institution>Departments of Molecular Biosciences, Chemistry, and the Chemistry of Life Processes Institute, Northwestern University</institution>, <addr-line>Evanston</addr-line>, <addr-line>IL</addr-line> <addr-line>60208</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8815-3372</contrib-id>
        <name>
          <surname>Kelleher</surname>
          <given-names>Neil L</given-names>
        </name>
        <!--n-kelleher@northwestern.edu-->
        <xref rid="COR1" ref-type="corresp"/>
        <aff><institution>Departments of Molecular Biosciences, Chemistry, and the Chemistry of Life Processes Institute, Northwestern University</institution>, <addr-line>Evanston</addr-line>, <addr-line>IL</addr-line> <addr-line>60208</addr-line>, <country country="US">USA</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +1 847 467 4362; Email: <email>n-kelleher@northwestern.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>07</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-11-19">
      <day>19</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>19</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <volume>50</volume>
    <issue>D1</issue>
    <fpage>D526</fpage>
    <lpage>D533</lpage>
    <history>
      <date date-type="accepted">
        <day>14</day>
        <month>11</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>06</day>
        <month>10</month>
        <year>2021</year>
      </date>
      <date date-type="received">
        <day>15</day>
        <month>8</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkab1086.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>The Human Proteoform Atlas (HPfA) is a web-based repository of experimentally verified human proteoforms on-line at <ext-link xlink:href="http://human-proteoform-atlas.org" ext-link-type="uri">http://human-proteoform-atlas.org</ext-link> and is a direct descendant of the Consortium of Top-Down Proteomics’ (CTDP) Proteoform Atlas. Proteoforms are the specific forms of protein molecules expressed by our cells and include the unique combination of post-translational modifications (PTMs), alternative splicing and other sources of variation deriving from a specific gene. The HPfA uses a FAIR system to assign persistent identifiers to proteoforms which allows for redundancy calling and tracking from prior and future studies in the growing community of proteoform biology and measurement. The HPfA is organized around open ontologies and enables flexible classification of proteoforms. To achieve this, a public registry of experimentally verified proteoforms was also created. Submission of new proteoforms can be processed through email <italic toggle="yes">via</italic><email xlink:href="nrtdphelp@northwestern.edu">nrtdphelp@northwestern.edu</email>, and future iterations of these proteoform atlases will help to organize and assign function to proteoforms, their PTMs and their complexes in the years ahead.</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Resource for Translational and Developmental Proteomics</institution>
          </institution-wrap>
        </funding-source>
        <award-id>P41 GM108569</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Paul G. Allen Frontiers Program</institution>
          </institution-wrap>
        </funding-source>
        <award-id>11715</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Library of Medicine</institution>
            <institution-id institution-id-type="DOI">10.13039/100000092</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>R21 LM013097</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="8"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Genomic data types probe human biology at the gene and transcript level, yet proteins are the direct source of much activity within our bodies and cells. Current, data on the expression of proteins is not complete as expressed proteins are often highly modified in ways which affect their structure and function. A single human gene usually expresses as a family of related forms of a protein. The term proteoforms has been introduced to refer to the specific molecular species of an expressed and translated gene including the precise combination of sequence variants, alternative splicing events, and post-translational modifications (PTMs) (Figure <xref rid="F1" ref-type="fig">1</xref>) (<xref rid="B1" ref-type="bibr">1</xref>). Proteoforms represent the main determinants of cellular phenotypes in protein-level biology yet remain largely understudied. According to UniProt, the total number of ‘canonical’ (i.e. the representative protein in UniProt for a given gene) human proteins across the entire proteome, is currently 20 386 (<xref rid="B2" ref-type="bibr">2</xref>). The number of proteoforms is larger and difficult to estimate because of phenomena such as mRNA splicing, PTMs, coding single-nucleotide polymorphism (cSNPs), and similar events (<xref rid="B3" ref-type="bibr">3</xref>).</p>
    <fig position="float" id="F1">
      <label>Figure 1.</label>
      <caption>
        <p>Scheme explaining the concept of a proteoform. A single gene (depicted at left) can be processed to generate different isoforms <italic toggle="yes">via</italic> alternative splicing of mRNA, which in combination with site-specific post-translational modifications (PTMs) and/or coding single-nucleotide polymorphism (cSNPs) that might be present in the population, generates different proteoforms (at right).</p>
      </caption>
      <graphic xlink:href="gkab1086fig1" position="float"/>
    </fig>
    <p>Understanding expressed proteoforms as the molecular phenotype is fundamental. One illustrative example is the case of the KRAS protein, which belongs to the RAS gene family. KRAS is alternatively spliced at the fourth exon, yielding the KRAS4A and KRAS4B isoforms (<xref rid="B4" ref-type="bibr">4</xref>). These genes encode for small GTPases which play important roles in cell growth and proliferation via the MAPK and PI3K pathways. The RAS gene family is also among the most frequently mutated in cancer, for example at residues G12, G13 or Q61 in KRAS4. Combined with oncogenic mutations, KRAS undergoes post-translational modification, including farnesylation and carboxymethylation of the C-terminal C185, which is critical for plasma membrane association. Given these sources of variation, there are thousands of possible theoretical proteoforms for the KRAS protein, with &lt;40 mapped thus far in cancer cell lines and tumors (<xref rid="B5" ref-type="bibr">5</xref>).</p>
    <p>The Protein Ontology (PRO) (<xref rid="B6" ref-type="bibr">6</xref>), another major protein knowledgebase, provides proteoform-level permanent identifiers, but only after a proteoform is published in the peer-reviewed literature and has been manually curated. This process leads to high quality annotations but, consequently, lags behind the experimental forefront. Therefore, at present, experimentally verified proteoform related information is mostly locked away from researchers by the lack of a findable, accessible, interoperable and reusable (FAIR) data infrastructure. As highlighted above for the KRAS protein, only those proteoforms representing different protein isoforms coming from alternatively spliced transcripts have their own unique protein identifiers in UniProt. For other types of proteoforms (proteins containing PTMs and protein variants) there is a need to normalize a widely accepted representation and to assign accession numbers, enabling interoperability between protein resources. Naturally, this limitation propagates to other bioinformatics resources that rely on UniProt as the way to represent proteins. Therefore, there is a need to enable a ‘proteoform-centric view’ for proteins, by creating resources and infrastructure for the handling, analysis, and validation of proteoforms. To overcome the shortage of dedicated biological cyberinfrastructure on human proteoforms we have established a Human Proteoform Atlas (HPfA) to serve as a registry for experimentally verified proteoforms and build upon the general Proteoform Atlas hosted by the Consortium of Top-Down Proteomics’ (CTDP) (<ext-link xlink:href="http://atlas.topdownproteomics.org/" ext-link-type="uri">http://atlas.topdownproteomics.org/</ext-link>).</p>
  </sec>
  <sec id="SEC2">
    <title>HUMAN PROTEOFORM ATLAS CONTENTS AND FEATURES</title>
    <p>We have established the HPfA, using FAIR principles, to durably store and identify proteoforms as they are experimentally verified from <italic toggle="yes">Homo sapiens</italic> (UniProt taxon identifier: 9606). The atlas, on-line at <ext-link xlink:href="http://human-proteoform-atlas.org" ext-link-type="uri">http://human-proteoform-atlas.org</ext-link>, is organized around existing open ontologies. It is currently structured to include Anatomy, Blood, Cancer, Cariology, Cell Lines, Cells, Immunology, and Neurologic Atlases, but new atlases can be instantiated as needed.</p>
    <p>At present, the Human Proteoform Atlas contains 37 071 unique experimentally verified proteoforms, each of which has been assigned a durable proteoform identifier. These proteoforms come from 30 datasets in 27 peer-reviewed publications (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>) (<xref rid="B7" ref-type="bibr">7–38</xref>), published by 15 unique laboratories over the last seven years (2014 to 2021), and represent 3055 protein isoforms derived from 2465 unique genes (∼13% of the protein-coding human genome). The proteoforms contain 369 separate types of modifications including phosphorylation (∼13% of the total PTMs observed), acetylation (∼43%), disulfides (∼2%), methylation (∼29%), Oxidation (∼2%), Dehydro (∼2%) palmitoylation (&lt;1%), farnesylation (&lt;1%), geranylation (&lt;1%), nitrosylation (&lt;1%), sulfinic acid (&lt;1%) and ADP-ribosylation (&lt;1%).</p>
    <p>The Human Proteoform Atlas is built around existing open and community-supported ontologies. Terms from these ontologies are used to classify proteoform entries. Currently, there are 68 ontologic terms used from seven ontologies (Figure <xref rid="F2" ref-type="fig">2A</xref>), including 11 different tissue types (Figure <xref rid="F2" ref-type="fig">2B</xref>), and 12 separate ontology terms associated with disease (Figure <xref rid="F2" ref-type="fig">2C</xref>).</p>
    <fig position="float" id="F2">
      <label>Figure 2.</label>
      <caption>
        <p>Proteoform breakdown in the HPfA by ontology in panel (<bold>A</bold>), tissue in (<bold>B</bold>) and human disease in (<bold>C</bold>). Ontology codes are: Uber-anatomy ontology (UBERON), Ontology for MIRNA Target (OMIT), Experimental Factor Ontology (EFO), Human Disease Ontology (DOID), Cell Line Ontology (CLO), Cell Ontology (CL) and BRENDA Tissue Ontology (BTO).</p>
      </caption>
      <graphic xlink:href="gkab1086fig2" position="float"/>
    </fig>
    <p>The Human Proteoform Atlas is designed to be open, scalable, and adopted as part of future community-driven activities. It creates the infrastructure needed to maximize dissemination of human proteoforms to the biomedical community while creating a single resource which leverages knowledge of human proteoforms. This repository links to protein-centric databases such as UniProt and has data visualization and integration tools.</p>
    <sec id="SEC2-1">
      <title>User interface</title>
      <p>Proteoforms and datasets contained in the Human Proteoform Atlas are broken down into eight current sub-atlases, displaying both dataset and proteoform counts and a description of that Atlas. Atlases are organized around existing open ontologies and can be broken down further by ontology terms or dataset.</p>
      <p>A user visiting the site first encounters a view of the eight sub-atlases, with dataset and proteoform counts. If the user is interested in the proteoforms associated with a particular cell type, for example, an eosinophil cell, they may select the Cell atlas which displays a breakdown of all ontological terms from the Cell ontology (CL) in the atlas. Selecting the eosinophil cell ontology term (CL:0000771), proceeds to an overview, including a description of the ontology term, links to EBI (<xref rid="B39" ref-type="bibr">39</xref>) and PURL (<xref rid="B40" ref-type="bibr">40</xref>), as well as a list of proteoforms associated with eosinophil cells, including protein associations, and modifications. These proteoforms can be further queried using the provided search tool. Proteoforms may be selected to give a detailed description, including biological and chemical proteoform accession numbers, associated proteins, ProForma sequence (<xref rid="B41" ref-type="bibr">41</xref>) and post-translational modifications (Figure <xref rid="F3" ref-type="fig">3</xref>). If the proteoform is from an enhanced dataset (see below), a graphical fragment map is populated and displayed, including various proteoform scores, experimental/observed masses, and dataset information.</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>Screenshots of the Human Proteoform Atlas. A proteoform page for PFR00000001011, an unmodified proteoform of the protein NEDD8.</p>
        </caption>
        <graphic xlink:href="gkab1086fig3" position="float"/>
      </fig>
      <p>If a user is interested in a specific gene or protein, these may be selected from the gene and protein tabs. Selecting a gene will display a summary page, including the full gene name, its symbol, chromosomal location, and various links to external resources, including but not limited to; HUGO Gene Nomenclature Committee (HGNC) (<xref rid="B42" ref-type="bibr">42</xref>), NCBI Reference Sequence Database (REFSEQ) (<xref rid="B43" ref-type="bibr">43</xref>), ENSEMBL (<xref rid="B44" ref-type="bibr">44</xref>), NCBI, and PubMed (Figure <xref rid="F4" ref-type="fig">4A</xref>). Selecting a protein displays a protein summary page that includes protein metadata obtained from UniProt (Figure <xref rid="F4" ref-type="fig">4B</xref>). If available, information about protein functionality, sequence data, and published interactions are also displayed, with the sequence data section displaying different features, including domains and motifs, known mutagenesis information, UniProt PTMs and their locations, and secondary structural information.</p>
      <fig position="float" id="F4">
        <label>Figure 4.</label>
        <caption>
          <p>Three screenshots from the Human Proteoform Atlas. (<bold>A</bold>) A gene entry summary page for NEDD8. (<bold>B</bold>) The protein summary page for NEDD8 including sequence, function and interaction data from UniProt. (<bold>C</bold>) A display of seven proteoforms associated with the NEDD8 gene.</p>
        </caption>
        <graphic xlink:href="gkab1086fig4" position="float"/>
      </fig>
      <p>A user may also select a specific dataset. Selecting the datasets tab displays a current list of submitted datasets (Figure <xref rid="F5" ref-type="fig">5A</xref>). When selected, a summary page for a dataset is displayed, featuring gene, protein/proteoform counts, any published manuscripts associated with the dataset (including PubMed links) and whether a dataset is enhanced (Figure <xref rid="F5" ref-type="fig">5B</xref>).</p>
      <fig position="float" id="F5">
        <label>Figure 5.</label>
        <caption>
          <p>Screenshots from the Human Proteoform Atlas. (<bold>A</bold>) A list of contributed datasets. (<bold>B</bold>) A dataset summary page.</p>
        </caption>
        <graphic xlink:href="gkab1086fig5" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="SEC3">
    <title>DEVELOPMENT AND IMPLEMENTATION</title>
    <p>We developed two seperate Application Programmable Interfaces (APIs); The Proteoform Repository and the Human Proteoform Atlas (Figure <xref rid="F6" ref-type="fig">6</xref>). The former, allows the verification and registration of identified proteoforms, <italic toggle="yes">via</italic> their ProForma (<xref rid="B41" ref-type="bibr">41</xref>) or sequence and PTMs, and is administered by the Consortium for Top-Down Proteomics (CTDP). The HPfA API is used to generate the UI for the Human Proteoform Atlas.</p>
    <fig position="float" id="F6">
      <label>Figure 6.</label>
      <caption>
        <p>Technical overview of the HPfA. The arrows indicate the flow of data between the Human Proteoform Atlas API and User Interface, the Proteoform Repository API and other external databases.</p>
      </caption>
      <graphic xlink:href="gkab1086fig6" position="float"/>
    </fig>
    <sec id="SEC3-1">
      <title>The Proteoform Repository API</title>
      <p>Proteoform (GET) requests are sent to The Proteoform Repository, and a biological and chemical proteoform record number (PFR) returned along with a validated ProForma string. In a collaboration with UniProt, regular reports of added proteoforms are included in the PTM / Processing section of associated protein entries (under Proteomic databases: TopDownProteomics). The Proteoform Repository acts as a standalone API that can be utilized outside of the Human Proteoform Atlas.</p>
      <p>The central databases for the Proteoform Repository were created using a MariaDB v10.3 database server hosted at Northwestern University. Web services were created using Microsoft's ASP.NET 5.0 framework using C# v9.0. Documentation of the web API was created using OpenAPI 3.0 and Swagger. All APIs support only ProForma version 2.0 and are not backward compatible with version 1.0. The PFRs generated are guaranteed to be immutable, persistent and unique by consistently processing the ProForma strings received. Each string is validated, translated to use a standard set of modifications, hashed and compared against a database of previously seen ProForma hashes (using a .NET process-level concurrency lock to prevent race conditions).</p>
    </sec>
    <sec id="SEC3-2">
      <title>The Human Proteoform Atlas</title>
      <p>The Human Proteoform Atlas (HPfA) consists of a web frontend and database backend established on a cloud platform (Microsoft Azure). The graphical user interface was implemented in Angular 10 using the Angular Material component library. The backend is comprised of a .NET 5 REST API, Entity Framework Core 5 for database access, and a Microsoft SQL Server database. The Human Proteoform Atlas API makes requests to The Proteoform Repository API during datasets submission. Proteoforms are validated and PFRs obtained and incorporated into the SQL database.</p>
    </sec>
    <sec id="SEC3-3">
      <title>External database interactions</title>
      <p>The Human Proteoform Atlas UI and backend API both interact with external APIs. The UI utilizes calls to the EBI UniProt API for protein entry information on Protein Overview pages, the HUGO Gene Nomenclature Committee API (<xref rid="B42" ref-type="bibr">42</xref>) for gene information, and to the EMBL-EBI Ontology API (<xref rid="B39" ref-type="bibr">39</xref>) for ontology data. During dataset submission the Human Proteoform Atlas backend REST API makes calls to the EMBL-EBI Ontology API for ontology term validation.</p>
    </sec>
    <sec id="SEC3-4">
      <title>Data collection and integration</title>
      <p>Custom .NET 5 scripts were created to facilitate the internal loading of existing public top-down proteomic data, hand-curated from the literature. In the interest of facilitating data exchange, we have used community-generated data standards including mzIdentML (<xref rid="B45" ref-type="bibr">45</xref>) and ProForma for the submission of datasets. Submitted proteoforms do not require full PTM localization (modifications may have a range), corresponding to a level 3 proteoform (or less) as described in Smith <italic toggle="yes">et al.</italic> (<xref rid="B46" ref-type="bibr">46</xref>). Users wanting to submit their own datasets can submit by emailing nrtdp-<email xlink:href="help@northwestern.edu">help@northwestern.edu</email>. Similar to the Proteomics Identification Database (PRIDE) (<xref rid="B47" ref-type="bibr">47</xref>), two types of dataset submission are available: standard and enhanced. The standard submission requires at least one target Atlas, a dataset name, any associated ontology terms, at least one associated publication (increasing confidence in the reported proteoforms), and a list of proteoforms as either ProForma or TopPIC strings (<xref rid="B48" ref-type="bibr">48</xref>). Optionally, external links to data repositories (such as PRIDE) can also be included, further increasing confidence in reported proteoforms. Enhanced submissions require mzIdentML files (which can be converted from TDReports generated in TDPortal and Thermo Fisher's ProSightPD). Each mzIdentML file may be given its own ontology terms, allowing the grouping of dataset files with different tissues/cell types into one dataset. Enhanced datasets contain spectral information, including fragment scores and coverage, allowing the creation of fragment maps.</p>
    </sec>
  </sec>
  <sec id="SEC4">
    <title>FUTURE DIRECTIONS</title>
    <p>Given the difficulty of housing all proteoform information from all biological domains in one central location, an open-source framework which creates a freestanding proteoform knowledgebase with the minimum functionality needed to store and display proteoforms would be desirable. This will allow other research communities to establish their own domain-specific proteoform knowledgebases. Associated with the Human Proteoform Project (<xref rid="B49" ref-type="bibr">49–51</xref>), proposed by the Consortium for Top-Down Proteomics, we plan to package and adapt an open-source codebase to build robust and scalable proteoform atlases of high-utility.</p>
    <p>Currently, dataset submission is coordinated <italic toggle="yes">via</italic> email and can be cumbersome. Therefore, we plan to work with the community to create a web and/or desktop submission client, allowing ontology validation, client-side proteoform validation and ORCID integration. In addition, the National Resource for Translational and Developmental Proteomics intends to modify their tool, ProSight Lite, to take advantage of the Chemical Proteoform API such that it will be able to easily upload individual user-identified chemical proteoforms.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC5">
    <title>DATA AVAILABILITY</title>
    <p>The Human Proteoform Atlas is a collaborative repository for human proteoforms (<ext-link xlink:href="http://human-proteoform-atlas.org" ext-link-type="uri">http://human-proteoform-atlas.org</ext-link>), with a publicly available API (<ext-link xlink:href="http://api.human-proteoform-atlas.org" ext-link-type="uri">http://api.human-proteoform-atlas.org</ext-link>). The Proteoform Repository is a publicly available web API that supports ProForma v2.0 submissions (<ext-link xlink:href="http://www.proteoform.org/api" ext-link-type="uri">http://www.proteoform.org/api</ext-link>). An open-source codebase is also available for the conversion of tdReports to mzIdentML files (<ext-link xlink:href="https://github.com/NRTDP/tdReport-to-mzIdentML" ext-link-type="uri">https://github.com/NRTDP/tdReport-to-mzIdentML</ext-link>), and an open-source ProForma parser is available as part of the Consortium for Top-Down Proteomics' open-source software solution (<ext-link xlink:href="https://github.com/topdownproteomics/sdk" ext-link-type="uri">https://github.com/topdownproteomics/sdk</ext-link>).</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkab1086_Supplemental_File</label>
      <media xlink:href="gkab1086_supplemental_file.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>We thank Paul Danis and the Board of Directors of the Consortium for Top-Down Proteomics for their engagement and support, and Hartmut Schlüter for advancing the Human Proteoform Atlas Initiative and devising the acronym, HPfA.</p>
  </ack>
  <sec id="SEC6">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkab1086#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC7">
    <title>FUNDING</title>
    <p>National Resource for Translational and Developmental Proteomics [P41 GM108569]; Paul G. Allen Frontiers Program [Award 11715]; National Library of Medicine [R21 LM013097]. Funding for open access charge: National Resource for Translational and Developmental Proteomics [P41 GM108569]; Paul G. Allen Frontiers Program [Award 11715]; National Library of Medicine [R21 LM013097].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. M.T.R., R.T.F. and N.L.K. contribute to the development of commercial proteomics software.</p>
  </sec>
  <notes id="NT1">
    <title>Notes</title>
    <p>Present address: Paul M. Thomas, AbbVie, Inc., 1401 Sheridan Rd, North Chicago,IL 60064, USA.</p>
  </notes>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>L.M.</given-names></string-name>, <string-name><surname>Kelleher</surname><given-names>N.L.</given-names></string-name>, <string-name><surname>Linial</surname><given-names>M.</given-names></string-name>, <string-name><surname>Goodlett</surname><given-names>D.</given-names></string-name>, <string-name><surname>Langridge-Smith</surname><given-names>P.</given-names></string-name>, <string-name><surname>Ah Goo</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Safford</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bonilla</surname><given-names>L.</given-names></string-name>, <string-name><surname>Kruppa</surname><given-names>G.</given-names></string-name>, <string-name><surname>Zubarev</surname><given-names>R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Proteoform: a single term describing protein complexity</article-title>. <source>Nat. Methods</source>. <year>2013</year>; <volume>10</volume>:<fpage>186</fpage>–<lpage>187</lpage>.<pub-id pub-id-type="pmid">23443629</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Consortium</surname><given-names>T.U.</given-names></string-name></person-group><article-title>UniProt: the universal protein knowledgebase in 2021</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>49</volume>:<fpage>D480</fpage>–<lpage>D489</lpage>.</mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aebersold</surname><given-names>R.</given-names></string-name>, <string-name><surname>Agar</surname><given-names>J.N.</given-names></string-name>, <string-name><surname>Amster</surname><given-names>I.J.</given-names></string-name>, <string-name><surname>Baker</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Bertozzi</surname><given-names>C.R.</given-names></string-name>, <string-name><surname>Boja</surname><given-names>E.S.</given-names></string-name>, <string-name><surname>Costello</surname><given-names>C.E.</given-names></string-name>, <string-name><surname>Cravatt</surname><given-names>B.F.</given-names></string-name>, <string-name><surname>Fenselau</surname><given-names>C.</given-names></string-name>, <string-name><surname>Garcia</surname><given-names>B.A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>How many human proteoforms are there</article-title>. <source>Nat. Chem. Biol.</source><year>2018</year>; <volume>14</volume>:<fpage>206</fpage>–<lpage>214</lpage>.<pub-id pub-id-type="pmid">29443976</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ntai</surname><given-names>I.</given-names></string-name>, <string-name><surname>Fornelli</surname><given-names>L.</given-names></string-name>, <string-name><surname>DeHart</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Hutton</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Doubleday</surname><given-names>P.F.</given-names></string-name>, <string-name><surname>LeDuc</surname><given-names>R.D.</given-names></string-name>, <string-name><surname>van Nispen</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Fellers</surname><given-names>R.T.</given-names></string-name>, <string-name><surname>Whiteley</surname><given-names>G.</given-names></string-name>, <string-name><surname>Boja</surname><given-names>E.S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Precise characterization of KRAS4b proteoforms in human colorectal cells and tumors reveals mutation/modification cross-talk</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2018</year>; <volume>115</volume>:<fpage>4140</fpage>–<lpage>4145</lpage>.<pub-id pub-id-type="pmid">29610327</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aebersold</surname><given-names>R.</given-names></string-name>, <string-name><surname>Agar</surname><given-names>J.N.</given-names></string-name>, <string-name><surname>Amster</surname><given-names>I.J.</given-names></string-name>, <string-name><surname>Baker</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Bertozzi</surname><given-names>C.R.</given-names></string-name>, <string-name><surname>Boja</surname><given-names>E.S.</given-names></string-name>, <string-name><surname>Costello</surname><given-names>C.E.</given-names></string-name>, <string-name><surname>Cravatt</surname><given-names>B.F.</given-names></string-name>, <string-name><surname>Fenselau</surname><given-names>C.</given-names></string-name>, <string-name><surname>Garcia</surname><given-names>B.A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>How many human proteoforms are there</article-title>. <source>Nat. Chem. Biol.</source><year>2018</year>; <volume>14</volume>:<fpage>206</fpage>–<lpage>214</lpage>.<pub-id pub-id-type="pmid">29443976</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Natale</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Arighi</surname><given-names>C.N.</given-names></string-name>, <string-name><surname>Blake</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Bona</surname><given-names>J.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Christie</surname><given-names>K.R.</given-names></string-name>, <string-name><surname>Cowart</surname><given-names>J.</given-names></string-name>, <string-name><surname>D’Eustachio</surname><given-names>P.</given-names></string-name>, <string-name><surname>Diehl</surname><given-names>A.D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Protein Ontology (PRO): enhancing and scaling up the representation of protein entities</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>D339</fpage>–<lpage>D346</lpage>.<pub-id pub-id-type="pmid">27899649</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ahlf</surname><given-names>D.R.</given-names></string-name>, <string-name><surname>Compton</surname><given-names>P.D.</given-names></string-name>, <string-name><surname>Tran</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Early</surname><given-names>B.P.</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>P.M.</given-names></string-name>, <string-name><surname>Kelleher</surname><given-names>N.L.</given-names></string-name></person-group><article-title>Evaluation of the compact high-field orbitrap for top-down proteomics of human cells</article-title>. <source>J. Proteome Res.</source><year>2012</year>; <volume>11</volume>:<fpage>4308</fpage>–<lpage>4314</lpage>.<pub-id pub-id-type="pmid">22746247</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sherma</surname><given-names>N.D.</given-names></string-name>, <string-name><surname>Borges</surname><given-names>C.R.</given-names></string-name>, <string-name><surname>Trenchevska</surname><given-names>O.</given-names></string-name>, <string-name><surname>Jarvis</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Rehder</surname><given-names>D.S.</given-names></string-name>, <string-name><surname>Oran</surname><given-names>P.E.</given-names></string-name>, <string-name><surname>Nelson</surname><given-names>R.W.</given-names></string-name>, <string-name><surname>Nedelkov</surname><given-names>D</given-names></string-name></person-group><article-title>Mass spectrometric immunoassay for the qualitative and quantitative analysis of the cytokine Macrophage Migration Inhibitory Factor (MIF)</article-title>. <source>Proteome Sci.</source><year>2014</year>; <volume>12</volume>:<fpage>52</fpage>.<pub-id pub-id-type="pmid">25328446</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cabras</surname><given-names>T.</given-names></string-name>, <string-name><surname>Sanna</surname><given-names>M.</given-names></string-name>, <string-name><surname>Manconi</surname><given-names>B.</given-names></string-name>, <string-name><surname>Fanni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Demelia</surname><given-names>L.</given-names></string-name>, <string-name><surname>Sorbello</surname><given-names>O.</given-names></string-name>, <string-name><surname>Iavarone</surname><given-names>F.</given-names></string-name>, <string-name><surname>Castagnola</surname><given-names>M.</given-names></string-name>, <string-name><surname>Faa</surname><given-names>G.</given-names></string-name>, <string-name><surname>Messana</surname><given-names>I.</given-names></string-name></person-group><article-title>Proteomic investigation of whole saliva in Wilson's disease</article-title>. <source>J. Proteomics</source>. <year>2015</year>; <volume>128</volume>:<fpage>154</fpage>–<lpage>163</lpage>.<pub-id pub-id-type="pmid">26254010</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>Y.C.</given-names></string-name>, <string-name><surname>Sumandea</surname><given-names>M.P.</given-names></string-name>, <string-name><surname>Larsson</surname><given-names>L.</given-names></string-name>, <string-name><surname>Moss</surname><given-names>R.L.</given-names></string-name>, <string-name><surname>Ge</surname><given-names>Y.</given-names></string-name></person-group><article-title>Dissecting human skeletal muscle troponin proteoforms by top-down mass spectrometry</article-title>. <source>J. Muscle Res. Cell Motil.</source><year>2015</year>; <volume>36</volume>:<fpage>169</fpage>–<lpage>181</lpage>.<pub-id pub-id-type="pmid">25613324</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Coelho Graça</surname><given-names>D.</given-names></string-name>, <string-name><surname>Hartmer</surname><given-names>R.</given-names></string-name>, <string-name><surname>Jabs</surname><given-names>W.</given-names></string-name>, <string-name><surname>Beris</surname><given-names>P.</given-names></string-name>, <string-name><surname>Clerici</surname><given-names>L.</given-names></string-name>, <string-name><surname>Stoermer</surname><given-names>C.</given-names></string-name>, <string-name><surname>Samii</surname><given-names>K.</given-names></string-name>, <string-name><surname>Hochstrasser</surname><given-names>D.</given-names></string-name>, <string-name><surname>Tsybin</surname><given-names>Y.O.</given-names></string-name>, <string-name><surname>Scherl</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Identification of hemoglobin variants by top-down mass spectrometry using selected diagnostic product ions</article-title>. <source>Anal. Bioanal. Chem.</source><year>2015</year>; <volume>407</volume>:<fpage>2837</fpage>–<lpage>2845</lpage>.<pub-id pub-id-type="pmid">25753013</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rehder</surname><given-names>D.S.</given-names></string-name>, <string-name><surname>Gundberg</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Booth</surname><given-names>S.L.</given-names></string-name>, <string-name><surname>Borges</surname><given-names>C.R.</given-names></string-name></person-group><article-title>Gamma-carboxylation and fragmentation of osteocalcin in human serum defined by mass spectrometry</article-title>. <source>Mol. Cell. Proteomics</source>. <year>2015</year>; <volume>14</volume>:<fpage>1546</fpage>–<lpage>1555</lpage>.<pub-id pub-id-type="pmid">25855755</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Trenchevska</surname><given-names>O.</given-names></string-name>, <string-name><surname>Sherma</surname><given-names>N.D.</given-names></string-name>, <string-name><surname>Oran</surname><given-names>P.E.</given-names></string-name>, <string-name><surname>Reaven</surname><given-names>P.D.</given-names></string-name>, <string-name><surname>Nelson</surname><given-names>R.W.</given-names></string-name>, <string-name><surname>Nedelkov</surname><given-names>D</given-names></string-name></person-group><article-title>Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants</article-title>. <source>J. Proteomics</source>. <year>2015</year>; <volume>116</volume>:<fpage>15</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">25549571</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yassine</surname><given-names>H.N.</given-names></string-name>, <string-name><surname>Trenchevska</surname><given-names>O.</given-names></string-name>, <string-name><surname>Ramrakhiani</surname><given-names>A.</given-names></string-name>, <string-name><surname>Parekh</surname><given-names>A.</given-names></string-name>, <string-name><surname>Koska</surname><given-names>J.</given-names></string-name>, <string-name><surname>Walker</surname><given-names>R.W.</given-names></string-name>, <string-name><surname>Billheimer</surname><given-names>D.</given-names></string-name>, <string-name><surname>Reaven</surname><given-names>P.D.</given-names></string-name>, <string-name><surname>Yen</surname><given-names>F.T.</given-names></string-name>, <string-name><surname>Nelson</surname><given-names>R.W.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The association of human apolipoprotein C-III sialylation proteoforms with plasma triglycerides</article-title>. <source>PLoS One</source>. <year>2015</year>; <volume>10</volume>:<fpage>e0144138</fpage>.<pub-id pub-id-type="pmid">26633899</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Azizkhanian</surname><given-names>I.</given-names></string-name>, <string-name><surname>Trenchevska</surname><given-names>O.</given-names></string-name>, <string-name><surname>Bashawri</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Koska</surname><given-names>J.</given-names></string-name>, <string-name><surname>Reaven</surname><given-names>P.D.</given-names></string-name>, <string-name><surname>Nelson</surname><given-names>R.W.</given-names></string-name>, <string-name><surname>Nedelkov</surname><given-names>D.</given-names></string-name>, <string-name><surname>Yassine</surname><given-names>H.N.</given-names></string-name></person-group><article-title>Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes</article-title>. <source>J. Clin. Lipidol.</source><year>2016</year>; <volume>10</volume>:<fpage>808</fpage>–<lpage>815</lpage>.<pub-id pub-id-type="pmid">27578111</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hoover</surname><given-names>M.E.</given-names></string-name>, <string-name><surname>Dang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Shomo</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Guan</surname><given-names>X.</given-names></string-name>, <string-name><surname>Marshall</surname><given-names>A.G.</given-names></string-name>, <string-name><surname>Freitas</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Young</surname><given-names>N.L.</given-names></string-name></person-group><article-title>Quantitative mass spectrometry reveals that intact histone H1 phosphorylations are variant specific and exhibit single molecule hierarchical dependence</article-title>. <source>Mol. Cell. Proteomics</source>. <year>2016</year>; <volume>15</volume>:<fpage>818</fpage>–<lpage>833</lpage>.<pub-id pub-id-type="pmid">26209608</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Durbin</surname><given-names>K.R.</given-names></string-name>, <string-name><surname>Fornelli</surname><given-names>L.</given-names></string-name>, <string-name><surname>Fellers</surname><given-names>R.T.</given-names></string-name>, <string-name><surname>Doubleday</surname><given-names>P.F.</given-names></string-name>, <string-name><surname>Narita</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kelleher</surname><given-names>N.L.</given-names></string-name></person-group><article-title>Quantitation and identification of thousands of human proteoforms below 30 kDa</article-title>. <source>J. Proteome Res.</source><year>2016</year>; <volume>15</volume>:<fpage>976</fpage>–<lpage>982</lpage>.<pub-id pub-id-type="pmid">26795204</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koska</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yassine</surname><given-names>H.</given-names></string-name>, <string-name><surname>Trenchevska</surname><given-names>O.</given-names></string-name>, <string-name><surname>Sinari</surname><given-names>S.</given-names></string-name>, <string-name><surname>Schwenke</surname><given-names>D.C.</given-names></string-name>, <string-name><surname>Yen</surname><given-names>F.T.</given-names></string-name>, <string-name><surname>Billheimer</surname><given-names>D.</given-names></string-name>, <string-name><surname>Nelson</surname><given-names>R.W.</given-names></string-name>, <string-name><surname>Nedelkov</surname><given-names>D.</given-names></string-name>, <string-name><surname>Reaven</surname><given-names>P.D.</given-names></string-name></person-group><article-title>Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes</article-title>. <source>J. Lipid Res.</source><year>2016</year>; <volume>57</volume>:<fpage>894</fpage>–<lpage>905</lpage>.<pub-id pub-id-type="pmid">26945091</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ntai</surname><given-names>I.</given-names></string-name>, <string-name><surname>LeDuc</surname><given-names>R.D.</given-names></string-name>, <string-name><surname>Fellers</surname><given-names>R.T.</given-names></string-name>, <string-name><surname>Erdmann-Gilmore</surname><given-names>P.</given-names></string-name>, <string-name><surname>Davies</surname><given-names>S.R.</given-names></string-name>, <string-name><surname>Rumsey</surname><given-names>J.</given-names></string-name>, <string-name><surname>Early</surname><given-names>B.P.</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>P.M.</given-names></string-name>, <string-name><surname>Li</surname><given-names>S.</given-names></string-name>, <string-name><surname>Compton</surname><given-names>P.D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Integrated bottom-up and top-down proteomics of patient-derived breast tumor xenografts</article-title>. <source>Mol. Cell. Proteomics</source>. <year>2016</year>; <volume>15</volume>:<fpage>45</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">26503891</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peró-Gascón</surname><given-names>R.</given-names></string-name>, <string-name><surname>Pont</surname><given-names>L.</given-names></string-name>, <string-name><surname>Benavente</surname><given-names>F.</given-names></string-name>, <string-name><surname>Barbosa</surname><given-names>J.</given-names></string-name>, <string-name><surname>Sanz-Nebot</surname><given-names>V.</given-names></string-name></person-group><article-title>Analysis of serum transthyretin by on-line immunoaffinity solid-phase extraction capillary electrophoresis mass spectrometry using magnetic beads</article-title>. <source>Electrophoresis</source>. <year>2016</year>; <volume>37</volume>:<fpage>1220</fpage>–<lpage>1231</lpage>.<pub-id pub-id-type="pmid">26842820</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pont</surname><given-names>L.</given-names></string-name>, <string-name><surname>Poturcu</surname><given-names>K.</given-names></string-name>, <string-name><surname>Benavente</surname><given-names>F.</given-names></string-name>, <string-name><surname>Barbosa</surname><given-names>J.</given-names></string-name>, <string-name><surname>Sanz-Nebot</surname><given-names>V.</given-names></string-name></person-group><article-title>Comparison of capillary electrophoresis and capillary liquid chromatography coupled to mass spectrometry for the analysis of transthyretin in human serum</article-title>. <source>J. Chromatogr. A</source>. <year>2016</year>; <volume>1444</volume>:<fpage>145</fpage>–<lpage>153</lpage>.<pub-id pub-id-type="pmid">27052822</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Trenchevska</surname><given-names>O.</given-names></string-name>, <string-name><surname>Yassine</surname><given-names>H.N.</given-names></string-name>, <string-name><surname>Borges</surname><given-names>C.R.</given-names></string-name>, <string-name><surname>Nelson</surname><given-names>R.W.</given-names></string-name>, <string-name><surname>Nedelkov</surname><given-names>D</given-names></string-name></person-group><article-title>Development of quantitative mass spectrometric immunoassay for serum amyloid A</article-title>. <source>Biomarkers</source>. <year>2016</year>; <volume>21</volume>:<fpage>743</fpage>–<lpage>751</lpage>.<pub-id pub-id-type="pmid">27308834</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yassine</surname><given-names>H.N.</given-names></string-name>, <string-name><surname>Trenchevska</surname><given-names>O.</given-names></string-name>, <string-name><surname>Dong</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Bashawri</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Koska</surname><given-names>J.</given-names></string-name>, <string-name><surname>Reaven</surname><given-names>P.D.</given-names></string-name>, <string-name><surname>Nelson</surname><given-names>R.W.</given-names></string-name>, <string-name><surname>Nedelkov</surname><given-names>D</given-names></string-name></person-group><article-title>The association of plasma cystatin C proteoforms with diabetic chronic kidney disease</article-title>. <source>Proteome Sci.</source><year>2016</year>; <volume>14</volume>:<fpage>7</fpage>.<pub-id pub-id-type="pmid">27019641</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anderson</surname><given-names>L.C.</given-names></string-name>, <string-name><surname>DeHart</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Kaiser</surname><given-names>N.K.</given-names></string-name>, <string-name><surname>Fellers</surname><given-names>R.T.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>D.F.</given-names></string-name>, <string-name><surname>Greer</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>LeDuc</surname><given-names>R.D.</given-names></string-name>, <string-name><surname>Blakney</surname><given-names>G.T.</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>P.M.</given-names></string-name>, <string-name><surname>Kelleher</surname><given-names>N.L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Identification and characterization of human proteoforms by top-down LC-21 Tesla FT-ICR mass spectrometry</article-title>. <source>J. Proteome Res.</source><year>2017</year>; <volume>16</volume>:<fpage>1087</fpage>–<lpage>1096</lpage>.<pub-id pub-id-type="pmid">27936753</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cleland</surname><given-names>T.P.</given-names></string-name>, <string-name><surname>DeHart</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Fellers</surname><given-names>R.T.</given-names></string-name>, <string-name><surname>VanNispen</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Greer</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>LeDuc</surname><given-names>R.D.</given-names></string-name>, <string-name><surname>Parker</surname><given-names>W.R.</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>P.M.</given-names></string-name>, <string-name><surname>Kelleher</surname><given-names>N.L.</given-names></string-name>, <string-name><surname>Brodbelt</surname><given-names>J.S.</given-names></string-name></person-group><article-title>High-throughput analysis of intact human proteins using UVPD and HCD on an Orbitrap mass spectrometer</article-title>. <source>J. Proteome Res.</source><year>2017</year>; <volume>16</volume>:<fpage>2072</fpage>–<lpage>2079</lpage>.<pub-id pub-id-type="pmid">28412815</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fornelli</surname><given-names>L.</given-names></string-name>, <string-name><surname>Durbin</surname><given-names>K.R.</given-names></string-name>, <string-name><surname>Fellers</surname><given-names>R.T.</given-names></string-name>, <string-name><surname>Early</surname><given-names>B.P.</given-names></string-name>, <string-name><surname>Greer</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>LeDuc</surname><given-names>R.D.</given-names></string-name>, <string-name><surname>Compton</surname><given-names>P.D.</given-names></string-name>, <string-name><surname>Kelleher</surname><given-names>N.L.</given-names></string-name></person-group><article-title>Advancing top-down analysis of the human proteome using a benchtop quadrupole-Orbitrap mass spectrometer</article-title>. <source>J. Proteome Res.</source><year>2017</year>; <volume>16</volume>:<fpage>609</fpage>–<lpage>618</lpage>.<pub-id pub-id-type="pmid">28152595</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pont</surname><given-names>L.</given-names></string-name>, <string-name><surname>Benavente</surname><given-names>F.</given-names></string-name>, <string-name><surname>Barbosa</surname><given-names>J.</given-names></string-name>, <string-name><surname>Sanz-Nebot</surname><given-names>V.</given-names></string-name></person-group><article-title>On-line immunoaffinity solid-phase extraction capillary electrophoresis mass spectrometry using Fab′antibody fragments for the analysis of serum transthyretin</article-title>. <source>Talanta</source>. <year>2017</year>; <volume>170</volume>:<fpage>224</fpage>–<lpage>232</lpage>.<pub-id pub-id-type="pmid">28501163</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pont</surname><given-names>L.</given-names></string-name>, <string-name><surname>Sanz-Nebot</surname><given-names>V.</given-names></string-name>, <string-name><surname>Vilaseca</surname><given-names>M.</given-names></string-name>, <string-name><surname>Jaumot</surname><given-names>J.</given-names></string-name>, <string-name><surname>Tauler</surname><given-names>R.</given-names></string-name>, <string-name><surname>Benavente</surname><given-names>F.</given-names></string-name></person-group><article-title>A chemometric approach for characterization of serum transthyretin in familial amyloidotic polyneuropathy type I (FAP-I) by electrospray ionization-ion mobility mass spectrometry</article-title>. <source>Talanta</source>. <year>2018</year>; <volume>181</volume>:<fpage>87</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">29426546</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vialaret</surname><given-names>J.</given-names></string-name>, <string-name><surname>Schmit</surname><given-names>P.O.</given-names></string-name>, <string-name><surname>Lehmann</surname><given-names>S.</given-names></string-name>, <string-name><surname>Gabelle</surname><given-names>A.</given-names></string-name>, <string-name><surname>Wood</surname><given-names>J.</given-names></string-name>, <string-name><surname>Bern</surname><given-names>M.</given-names></string-name>, <string-name><surname>Paape</surname><given-names>R.</given-names></string-name>, <string-name><surname>Suckau</surname><given-names>D.</given-names></string-name>, <string-name><surname>Kruppa</surname><given-names>G.</given-names></string-name>, <string-name><surname>Hirtz</surname><given-names>C.</given-names></string-name></person-group><article-title>Identification of multiple proteoforms biomarkers on clinical samples by routine top-down approaches</article-title>. <source>Data Brief</source>. <year>2018</year>; <volume>18</volume>:<fpage>1013</fpage>–<lpage>1021</lpage>.<pub-id pub-id-type="pmid">29900270</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dai</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Buxton</surname><given-names>K.E.</given-names></string-name>, <string-name><surname>Schaffer</surname><given-names>L.V.</given-names></string-name>, <string-name><surname>Miller</surname><given-names>R.M.</given-names></string-name>, <string-name><surname>Millikin</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Scalf</surname><given-names>M.</given-names></string-name>, <string-name><surname>Frey</surname><given-names>B.L.</given-names></string-name>, <string-name><surname>Shortreed</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>L.M.</given-names></string-name></person-group><article-title>Constructing human proteoform families using intact-mass and top-down proteomics with a multi-protease global post-translational modification discovery database</article-title>. <source>J. Proteome Res.</source><year>2019</year>; <volume>18</volume>:<fpage>3671</fpage>–<lpage>3680</lpage>.<pub-id pub-id-type="pmid">31479276</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>D.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Cupp-Sutton</surname><given-names>K.A.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>S.</given-names></string-name></person-group><article-title>Deep intact proteoform characterization in human cell lysate using high-pH and low-pH reversed-phase liquid chromatography</article-title>. <source>J. Am. Soc. Mass Spectrom.</source><year>2019</year>; <volume>30</volume>:<fpage>2502</fpage>–<lpage>2513</lpage>.<pub-id pub-id-type="pmid">31755044</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Contini</surname><given-names>C.</given-names></string-name>, <string-name><surname>Firinu</surname><given-names>D.</given-names></string-name>, <string-name><surname>Serrao</surname><given-names>S.</given-names></string-name>, <string-name><surname>Manconi</surname><given-names>B.</given-names></string-name>, <string-name><surname>Olianas</surname><given-names>A.</given-names></string-name>, <string-name><surname>Cinetto</surname><given-names>F.</given-names></string-name>, <string-name><surname>Cossu</surname><given-names>F.</given-names></string-name>, <string-name><surname>Castagnola</surname><given-names>M.</given-names></string-name>, <string-name><surname>Messana</surname><given-names>I.</given-names></string-name>, <string-name><surname>Del Giacco</surname><given-names>S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>RP-HPLC-ESI-IT mass spectrometry reveals significant variations of the human salivary protein profile associated with predominantly antibody deficiencies</article-title>. <source>J. Clin. Immunol.</source><year>2020</year>; <volume>40</volume>:<fpage>329</fpage>–<lpage>339</lpage>.<pub-id pub-id-type="pmid">31916122</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dubois</surname><given-names>C.</given-names></string-name>, <string-name><surname>Payen</surname><given-names>D.</given-names></string-name>, <string-name><surname>Simon</surname><given-names>S.</given-names></string-name>, <string-name><surname>Junot</surname><given-names>C.</given-names></string-name>, <string-name><surname>Fenaille</surname><given-names>F.</given-names></string-name>, <string-name><surname>Morel</surname><given-names>N.</given-names></string-name>, <string-name><surname>Becher</surname><given-names>F.</given-names></string-name></person-group><article-title>Top-down and bottom-up proteomics of circulating S100A8/S100A9 in plasma of septic shock patients</article-title>. <source>J. Proteome Res.</source><year>2020</year>; <volume>19</volume>:<fpage>914</fpage>–<lpage>925</lpage>.<pub-id pub-id-type="pmid">31913637</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schmidt</surname><given-names>A.</given-names></string-name>, <string-name><surname>Farine</surname><given-names>H.</given-names></string-name>, <string-name><surname>Keller</surname><given-names>M.P.</given-names></string-name>, <string-name><surname>Sebastian</surname><given-names>A.</given-names></string-name>, <string-name><surname>Kozera</surname><given-names>L.</given-names></string-name>, <string-name><surname>Welford</surname><given-names>R.W.D.</given-names></string-name>, <string-name><surname>Strasser</surname><given-names>D.S.</given-names></string-name></person-group><article-title>Immunoaffinity targeted mass spectrometry analysis of human plasma samples reveals an imbalance of active and inactive CXCL10 in primary Sjögren's syndrome disease patients</article-title>. <source>J. Proteome Res.</source><year>2020</year>; <volume>19</volume>:<fpage>4196</fpage>–<lpage>4209</lpage>.<pub-id pub-id-type="pmid">32870689</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Soler-Ventura</surname><given-names>A.</given-names></string-name>, <string-name><surname>Gay</surname><given-names>M.</given-names></string-name>, <string-name><surname>Jodar</surname><given-names>M.</given-names></string-name>, <string-name><surname>Vilanova</surname><given-names>M.</given-names></string-name>, <string-name><surname>Castillo</surname><given-names>J.</given-names></string-name>, <string-name><surname>Arauz-Garofalo</surname><given-names>G.</given-names></string-name>, <string-name><surname>Villarreal</surname><given-names>L.</given-names></string-name>, <string-name><surname>Ballescà</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Vilaseca</surname><given-names>M.</given-names></string-name>, <string-name><surname>Oliva</surname><given-names>R.</given-names></string-name></person-group><article-title>Characterization of human sperm protamine proteoforms through a combination of top-down and bottom-up mass spectrometry approaches</article-title>. <source>J. Proteome Res.</source><year>2020</year>; <volume>19</volume>:<fpage>221</fpage>–<lpage>237</lpage>.<pub-id pub-id-type="pmid">31703166</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>X.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>D.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>L.</given-names></string-name></person-group><article-title>Toward a universal sample preparation method for denaturing top-down proteomics of complex proteomes</article-title>. <source>J. Proteome Res.</source><year>2020</year>; <volume>19</volume>:<fpage>3315</fpage>–<lpage>3325</lpage>.<pub-id pub-id-type="pmid">32419461</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>M.</given-names></string-name>, <string-name><surname>Uwugiaren</surname><given-names>N.</given-names></string-name>, <string-name><surname>Williams</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Moore</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>R.</given-names></string-name>, <string-name><surname>Goodlett</surname><given-names>D.</given-names></string-name>, <string-name><surname>Dapic</surname><given-names>I.</given-names></string-name>, <string-name><surname>Paša-Tolić</surname><given-names>L.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y.</given-names></string-name></person-group><article-title>Sensitive top-down proteomics analysis of a low number of mammalian cells using a nanodroplet sample processing platform</article-title>. <source>Anal. Chem.</source><year>2020</year>; <volume>92</volume>:<fpage>7087</fpage>–<lpage>7095</lpage>.<pub-id pub-id-type="pmid">32374172</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schaffer</surname><given-names>L.V.</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>L.C.</given-names></string-name>, <string-name><surname>Butcher</surname><given-names>D.S.</given-names></string-name>, <string-name><surname>Shortreed</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Miller</surname><given-names>R.M.</given-names></string-name>, <string-name><surname>Pavelec</surname><given-names>C.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>L.M.</given-names></string-name></person-group><article-title>Construction of human proteoform families from 21 Tesla Fourier transform ion cyclotron resonance mass spectrometry top-down proteomic data</article-title>. <source>J. Proteome Res.</source><year>2021</year>; <volume>20</volume>:<fpage>317</fpage>–<lpage>325</lpage>.<pub-id pub-id-type="pmid">33074679</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Madeira</surname><given-names>F.</given-names></string-name>, <string-name><surname>Madhusoodanan</surname><given-names>N.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>J.</given-names></string-name>, <string-name><surname>Tivey</surname><given-names>A.R.N.</given-names></string-name>, <string-name><surname>Lopez</surname><given-names>R.</given-names></string-name></person-group><article-title>Using EMBL-EBI services via web interface and programmatically via web services</article-title>. <source>Curr. Protoc. Bioinformatics</source>. <year>2019</year>; <volume>66</volume>:<fpage>e74</fpage>.<pub-id pub-id-type="pmid">31039604</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ong</surname><given-names>E.</given-names></string-name>, <string-name><surname>Xiang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>B.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>J.</given-names></string-name>, <string-name><surname>Mungall</surname><given-names>C.</given-names></string-name>, <string-name><surname>Courtot</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ruttenberg</surname><given-names>A.</given-names></string-name>, <string-name><surname>He</surname><given-names>Y.</given-names></string-name></person-group><article-title>Ontobee: a linked ontology data server to support ontology term dereferencing, linkage, query and integration</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>45</volume>:<fpage>D347</fpage>–<lpage>D352</lpage>.<pub-id pub-id-type="pmid">27733503</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>LeDuc</surname><given-names>R.D.</given-names></string-name>, <string-name><surname>Schwämmle</surname><given-names>V.</given-names></string-name>, <string-name><surname>Shortreed</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Cesnik</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Solntsev</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Shaw</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Martin</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Vizcaino</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Alpi</surname><given-names>E.</given-names></string-name>, <string-name><surname>Danis</surname><given-names>P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>ProForma: a standard proteoform notation</article-title>. <source>J. Proteome Res.</source><year>2018</year>; <volume>17</volume>:<fpage>1321</fpage>–<lpage>1325</lpage>.<pub-id pub-id-type="pmid">29397739</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eyre</surname><given-names>T.A.</given-names></string-name>, <string-name><surname>Ducluzeau</surname><given-names>F.</given-names></string-name>, <string-name><surname>Sneddon</surname><given-names>T.P.</given-names></string-name>, <string-name><surname>Povey</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bruford</surname><given-names>E.A.</given-names></string-name>, <string-name><surname>Lush</surname><given-names>M.J.</given-names></string-name></person-group><article-title>The HUGO gene nomenclature database, 2006 updates</article-title>. <source>Nucleic Acids Res.</source><year>2006</year>; <volume>34</volume>:<fpage>D319</fpage>–<lpage>D321</lpage>.<pub-id pub-id-type="pmid">16381876</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O’Leary</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>M.W.</given-names></string-name>, <string-name><surname>Brister</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Ciufo</surname><given-names>S.</given-names></string-name>, <string-name><surname>Haddad</surname><given-names>D.</given-names></string-name>, <string-name><surname>McVeigh</surname><given-names>R.</given-names></string-name>, <string-name><surname>Rajput</surname><given-names>B.</given-names></string-name>, <string-name><surname>Robbertse</surname><given-names>B.</given-names></string-name>, <string-name><surname>Smith-White</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ako-Adjei</surname><given-names>D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>D733</fpage>–<lpage>D745</lpage>.<pub-id pub-id-type="pmid">26553804</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yates</surname><given-names>A.D.</given-names></string-name>, <string-name><surname>Achuthan</surname><given-names>P.</given-names></string-name>, <string-name><surname>Akanni</surname><given-names>W.</given-names></string-name>, <string-name><surname>Allen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Allen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Alvarez-Jarreta</surname><given-names>J.</given-names></string-name>, <string-name><surname>Amode</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Armean</surname><given-names>I.M.</given-names></string-name>, <string-name><surname>Azov</surname><given-names>A.G.</given-names></string-name>, <string-name><surname>Bennett</surname><given-names>R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Ensembl 2020</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D682</fpage>–<lpage>D688</lpage>.<pub-id pub-id-type="pmid">31691826</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vizcaíno</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Mayer</surname><given-names>G.</given-names></string-name>, <string-name><surname>Perkins</surname><given-names>S.</given-names></string-name>, <string-name><surname>Barsnes</surname><given-names>H.</given-names></string-name>, <string-name><surname>Vaudel</surname><given-names>M.</given-names></string-name>, <string-name><surname>Perez-Riverol</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ternent</surname><given-names>T.</given-names></string-name>, <string-name><surname>Uszkoreit</surname><given-names>J.</given-names></string-name>, <string-name><surname>Eisenacher</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fischer</surname><given-names>L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The mzIdentML data standard version 1.2, supporting advances in proteome informatics</article-title>. <source>Mol. Cell. Proteomics</source>. <year>2017</year>; <volume>16</volume>:<fpage>1275</fpage>–<lpage>1285</lpage>.<pub-id pub-id-type="pmid">28515314</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>L.M.</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>P.M.</given-names></string-name>, <string-name><surname>Shortreed</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Schaffer</surname><given-names>L.V.</given-names></string-name>, <string-name><surname>Fellers</surname><given-names>R.T.</given-names></string-name>, <string-name><surname>LeDuc</surname><given-names>R.D.</given-names></string-name>, <string-name><surname>Tucholski</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ge</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Agar</surname><given-names>J.N.</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>L.C.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A five-level classification system for proteoform identifications</article-title>. <source>Nat. Methods</source>. <year>2019</year>; <volume>16</volume>:<fpage>939</fpage>–<lpage>940</lpage>.<pub-id pub-id-type="pmid">31451767</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Perez-Riverol</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Csordas</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bai</surname><given-names>J.</given-names></string-name>, <string-name><surname>Bernal-Llinares</surname><given-names>M.</given-names></string-name>, <string-name><surname>Hewapathirana</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kundu</surname><given-names>D.J.</given-names></string-name>, <string-name><surname>Inuganti</surname><given-names>A.</given-names></string-name>, <string-name><surname>Griss</surname><given-names>J.</given-names></string-name>, <string-name><surname>Mayer</surname><given-names>G.</given-names></string-name>, <string-name><surname>Eisenacher</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The PRIDE database and related tools and resources in 2019: improving support for quantification data</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D442</fpage>–<lpage>D450</lpage>.<pub-id pub-id-type="pmid">30395289</pub-id></mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kou</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Xun</surname><given-names>L.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X.</given-names></string-name></person-group><article-title>TopPIC: a software tool for top-down mass spectrometry-based proteoform identification and characterization</article-title>. <source>Bioinformatics</source>. <year>2016</year>; <volume>32</volume>:<fpage>3495</fpage>–<lpage>3497</lpage>.<pub-id pub-id-type="pmid">27423895</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>L.</given-names></string-name>, <string-name><surname>Agar</surname><given-names>J.</given-names></string-name>, <string-name><surname>Chamot-Rooke</surname><given-names>J.</given-names></string-name>, <string-name><surname>Danis</surname><given-names>P.</given-names></string-name>, <string-name><surname>Ge</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Loo</surname><given-names>J.</given-names></string-name>, <string-name><surname>Pasa-Tolic</surname><given-names>L.</given-names></string-name>, <string-name><surname>Tsybin</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Kelleher</surname><given-names>N</given-names></string-name></person-group><article-title>The human proteoform project: a plan to define the human proteome</article-title>. <year>2020</year>; <comment>Preprints doi:</comment><comment>19 October 2020, preprint: not peer reviewed</comment><uri xlink:href="https://www.preprints.org/manuscript/202010.0368/v1">https://www.preprints.org/manuscript/202010.0368/v1</uri>.</mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Burnum-Johnson</surname><given-names>K.E.</given-names></string-name>, <string-name><surname>Conrads</surname><given-names>T.P.</given-names></string-name>, <string-name><surname>Drake</surname><given-names>R.R.</given-names></string-name>, <string-name><surname>Herr</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>Iyengar</surname><given-names>R.</given-names></string-name>, <string-name><surname>Kelly</surname><given-names>R.T.</given-names></string-name>, <string-name><surname>Lundberg</surname><given-names>E.</given-names></string-name>, <string-name><surname>MacCoss</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Naba</surname><given-names>A.</given-names></string-name>, <string-name><surname>Nolan</surname><given-names>G.P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>New views of old proteins: clarifying the enigmatic proteome</article-title>. <year>2021</year>; <comment>arXiv doi:</comment><comment>17 August 2021, preprint: not peer reviewed</comment><uri xlink:href="https://arxiv.org/abs/2108.07660">https://arxiv.org/abs/2108.07660</uri>.</mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>L.M.</given-names></string-name>, <string-name><surname>Agar</surname><given-names>J.N.</given-names></string-name>, <string-name><surname>Chamot-Rooke</surname><given-names>J.</given-names></string-name>, <string-name><surname>Danis</surname><given-names>P.O.</given-names></string-name>, <string-name><surname>Ge</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Loo</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Paša-Tolić</surname><given-names>L.</given-names></string-name>, <string-name><surname>Tsybin</surname><given-names>Y.O.</given-names></string-name>, <string-name><surname>Kelleher</surname><given-names>N.L.</given-names></string-name><collab>The Consortium for Top-Down Proteomics</collab></person-group><article-title>The human proteoform project: defining the human proteome</article-title>. <source>Sci. Adv.</source><year>2021</year>; <volume>7</volume>:<fpage>eabk0734</fpage>.<pub-id pub-id-type="pmid">34767442</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
